New Data Show Use of Abbott's FreeStyle® Libre System Significantly Reduces HbA1c Levels in People Living with Type 2 Diabetes - PRNewswire

New Data Show Use of Abbott's FreeStyle® Libre System Significantly Reduces HbA1c Levels in People Living with Type 2 Diabetes - PRNewswire

SAN FRANCISCO, June 8, 2019 /PRNewswire/ -- Today Abbott (NYSE: ABT) announced new data showing use of its FreeStyle Libre system, the company's revolutionary..."/>

Search Searching for your content...

No results found. Please change your search terms and try again.

New Data Show Use of Abbott's FreeStyle® Libre System Significantly Reduces HbA1c Levels in People Living with Type 2 Diabetes - PRNewswire

Website content discovery tool for research, personalization, optimization, marketing, and analytics.
START YOUR FREE ONE MONTH TRIAL